(Q34343391)

1 August 2017

title

Risks associated with the therapeutic use of fluoroquinolones (English)

1 reference

1 August 2017

Ralf Stahlmann

1

1 reference

1 August 2017

Hartmut M Lode

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

7 May 2013

1 reference

Expert Opinion on Drug Safety

1 August 2017

published in

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

497-505

1 reference

Antimicrobial safety: focus on fluoroquinolones

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Safety profile of the fluoroquinolones: focus on levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Clinical toxicological aspects of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Improving known classes of antibiotics: an optimistic approach for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Current status of Clostridium difficile infection epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Hepatic safety of antibiotics used in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Drug interactions during therapy with three major groups of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Ciprofloxacin-induced toxic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Oral fluoroquinolones and the risk of retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Association between oral fluoroquinolones and retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Antimicrobial-associated QT interval prolongation: pointes of interest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Effect of macrolide and fluoroquinolone antibacterials on the risk of ventricular arrhythmia and cardiac arrest: an observational study in Italy using case-control, case-crossover and case-time-control designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Azithromycin and the risk of cardiovascular death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolones and the risk of serious arrhythmia: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Severe QT interval prolongation associated with moxifloxacin: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Outpatient gatifloxacin therapy and dysglycemia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Severe dysglycemia with the fluoroquinolones: a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Ciprofloxacin safety in paediatrics: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Severe acute polyarthritis in a child after high doses of moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Death following bilateral complete Achilles tendon rupture in a patient on fluoroquinolone therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolones and risk of Achilles tendon disorders: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolone-associated tendinopathy: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Synergistic effects of dexamethasone and quinolones on human-derived tendon cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Safety considerations of fluoroquinolones in the elderly: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Geriatric pharmacology and pharmacotherapy education for health professionals and students: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

Host and Pathogen Factors forClostridium difficileInfection and Colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2013.796362

10.1517/14740338.2013.796362

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference